Author:
Li Chunmei,Su Chunyu,Wang Yu,Gao Yonglin,Wang Hongbo,Tian Jingwei,Fu Fenghua
Funder
Ministry of Science and Technology of the People's Republic of China
Subject
Toxicology,General Medicine
Reference22 articles.
1. Xuezhikang ameliorates contrast media-induced nephropathy in rats via suppression of oxidative stress, inflammatory responses and apoptosis;Chu;Ren. Fail.,2016
2. Isoflavones enhance pharmacokinetic exposure of active lovastatin acid via the upregulation of carboxylesterase in high-fat diet mice after oral administration of Xuezhikang capsules;Feng;Acta Pharmacol. Sin.,2018
3. Toxicological evaluation of, red rice yeast extract, Xuezhikang: acute, 26-week chronic and genotoxicity studies;Gao;Regul. Toxicol. Pharmacol.,2020
4. Nonclinical safety of Astilbin: a 4-week oral toxicity study in rats with genotoxicity, chromosomal aberration, and mammalian micronucleus tests;Gao;Food Chem. Toxicol.,2017
5. A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs;Gao;Regul. Toxicol. Pharmacol.,2019